Supply Chain

Could fluorescent silk proteins be the answer to the pharmaceutical industry's fake drug problem?

From improved supply chains to improved adherence, we explore how smart solutions can transform packaging – and the patient experience.

UC Davis joins Orgenesis’ point-of-care network to develop and commercialize cell and gene therapies in house.

A collaboration for improved supply chain visibility.

Only when greater transparency is established in supply chains can the industry begin to iron out problems with drug shortages.

How are digital technologies addressing supply chain challenges?

Contract laboratories need to be treated as equal partners rather than service providers.

What challenges are companies facing in the post-FMD climate?

Brexit is a serious challenge for UK businesses trading with the EU.

Six members of the US's congress demand answers from the FDA as the risk of heparin shortages loom.